Cawkwell Gail

CIK 00017611672 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001761167

Recent Transactions

41 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-07-01−15,000→ 45,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-07-01+15,000→ 15,000 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-07-01$10.37/sh−5,407→ 9,593 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2023-02-01+105,000→ 105,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-02-01+30,000→ 30,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-07-01+60,000→ 60,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2022-07-01+210,000→ 210,000 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-02-12$15.80/sh−320→ 35,740 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-01-27+6,600→ 36,060 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-01-27+11,300→ 11,300 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-12-31$16.29/sh−2,455→ 29,460 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-11-12$19.04/sh−319→ 31,915 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-08-12$15.28/sh−319→ 32,234 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-12$17.75/sh−319→ 32,553 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-02-12$31.32/sh−319→ 32,872 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-01-22+12,600→ 33,191 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-01-22+19,700→ 19,700 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-12-31$24.70/sh−706→ 20,591 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-11-12$38.52/sh−319→ 21,297 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-08-12$53.44/sh−319→ 21,616 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-05-12$89.05/sh−319→ 21,935 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-02-12$96.74/sh−319→ 22,254 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2020-01-23+6,900→ 6,900 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-01-23+4,200→ 22,573 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-12-31$125.00/sh−262→ 18,722 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-12-31−262→ 20,779 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-12-31$54.63/sh+262→ 18,984 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-12-31$123.92/sh−349→ 18,373 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-12-26$54.63/sh+54→ 18,776 total
Sale
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-12-26$125.00/sh−54→ 18,722 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-12-26−54→ 21,041 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-12-03−80→ 21,095 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-12-03$54.63/sh+80→ 18,722 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-11-12$83.02/sh−319→ 18,642 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-08-12$65.89/sh−319→ 18,961 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-05-12$86.66/sh−319→ 19,280 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-04-18$54.63/sh+1,750→ 19,599 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-04-18−1,750→ 21,175 total
Tax Payment
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-02-12$111.05/sh−1,276→ 17,849 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-01-16+6,700→ 6,700 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-01-16+4,100→ 19,125 total

Companies

Recent Filings

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37

NEW YORK, NY, 10001

View on SEC.gov